Company

Stargazer Pharmaceuticals Inc.

Stargazer Pharmaceuticals develops pharmaceutical therapies to address medical needs.

About

Founded in 2018 and based in Boston, US, Stargazer Pharmaceuticals develops pharmaceutical products. In November 2020, it raised USD 57.00 mn in Series A funding led by Novo Holdings, with participation from Canaan Partners, Pontifax Venture Capital, and VenBio Partners.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in